All Practice Exams

Free Practice Questions for Kuwait Board Family Medicine

Exam-style questions and explanations by OpenExamPrep.

✓ No registration✓ No credit card
100+ Questions
100% Free

Loading practice questions...

Same family resources

Explore More Kuwait Board Specialty Exams

Continue into nearby exams from the same family. Each card keeps practice questions, study guides, flashcards, videos, and articles in one place.

Sample Kuwait Board Family Medicine Practice Questions

Try these sample questions to review concepts for the Kuwait Board Family Medicine exam. Each question includes a detailed explanation. Start the interactive quiz above for the full 100+ question experience with AI tutoring.

1A 54-year-old man with newly diagnosed type 2 diabetes mellitus presents for management. His body mass index is 31 kg/m², blood pressure is 138/84 mmHg, and baseline HbA1c is 8.4% (68 mmol/mol). His estimated glomerular filtration rate (eGFR) is 78 mL/min/1.73 m² with a urine albumin-to-creatinine ratio (uACR) of 1.8 mg/mmol. His past medical history includes an ST-elevation myocardial infarction 2 years ago treated with a drug-eluting stent. In addition to lifestyle counseling, which initial pharmacotherapy regimen is most appropriate?
A.Metformin monotherapy with rapid titration to 1,000 mg twice daily
B.Metformin combined with an SGLT2 inhibitor or a GLP-1 receptor agonist with proven cardiovascular benefit
C.Sulfonylurea monotherapy such as gliclazide modified-release 30 mg daily
D.Dipeptidyl peptidase-4 (DPP-4) inhibitor monotherapy such as sitagliptin 100 mg daily
Explanation: Current international and regional clinical practice guidelines for type 2 diabetes recommend that patients with established atherosclerotic cardiovascular disease receive an agent with proven cardiovascular benefit—either an SGLT2 inhibitor or a GLP-1 receptor agonist—independent of baseline HbA1c, combined with metformin. This dual-pathway approach significantly reduces major adverse cardiovascular events (MACE) and cardiovascular mortality compared to metformin monotherapy.
2A 48-year-old woman with a 5-year history of type 2 diabetes mellitus presents for routine chronic disease follow-up. Repeated seated clinic blood pressures over three visits average 144/92 mmHg. Routine spot urine testing demonstrates an elevated urine albumin-to-creatinine ratio of 18 mg/mmol (confirmed on a repeat early-morning sample). Serum creatinine is 84 μmol/L with an eGFR of 82 mL/min/1.73 m² and serum potassium is 4.4 mmol/L. Which antihypertensive drug class is the most appropriate first-line therapy?
A.Angiotensin-converting enzyme (ACE) inhibitor or angiotensin receptor blocker (ARB)
B.Dihydropyridine calcium channel blocker
C.Thiazide-like diuretic
D.Cardioselective beta-blocker
Explanation: In patients with diabetes and persistent albuminuria (uACR >= 3 mg/mmol), an ACE inhibitor or an ARB is the first-line antihypertensive class. These agents reduce intraglomerular pressure, decrease proteinuria, and slow the progression of diabetic kidney disease beyond their blood-pressure-lowering effect.
3A 56-year-old male smoker with hypertension and newly detected fasting lipid panel attends the primary care clinic. His calculated 10-year atherosclerotic cardiovascular disease (ASCVD) risk is 22.5%. Laboratory analysis reveals total cholesterol 6.2 mmol/L, LDL-C 4.2 mmol/L, HDL-C 0.9 mmol/L, and triglycerides 2.4 mmol/L. His liver enzymes and renal function are normal. Which lipid-lowering intervention is indicated for primary prevention?
A.Moderate-intensity statin such as pravastatin 20 mg daily
B.Fenofibrate 145 mg daily alone to address elevated triglycerides
C.High-intensity statin such as atorvastatin 40 to 80 mg or rosuvastatin 20 to 40 mg daily
D.Dietary modification alone with repeat lipid panel in 12 months
Explanation: Adults aged 40 to 75 years at high cardiovascular risk (10-year ASCVD risk >= 20%) warrant high-intensity statin therapy aiming for an LDL-C reduction of at least 50% from baseline. Atorvastatin 40-80 mg or rosuvastatin 20-40 mg daily are the standard evidence-based high-intensity regimens for this clinical profile.
4A 62-year-old man with a 12-year history of type 2 diabetes mellitus, ischemic cardiomyopathy (ejection fraction 42%), and stage 3a chronic kidney disease presents for glycemic review. His current medications include metformin 500 mg twice daily, bisoprolol 5 mg daily, and ramipril 5 mg daily. His latest laboratory results show HbA1c 7.9% (63 mmol/mol), serum creatinine 135 μmol/L, eGFR 48 mL/min/1.73 m², and uACR 28 mg/mmol. Which medication should be added next to reduce cardiorenal progression?
A.Glimepiride 2 mg once daily
B.Pioglitazone 15 mg once daily
C.Acarbose 50 mg three times daily with meals
D.Dapagliflozin 10 mg or empagliflozin 10 mg once daily
Explanation: SGLT2 inhibitors (such as dapagliflozin or empagliflozin) have established robust evidence for slowing chronic kidney disease progression, reducing heart failure hospitalizations, and decreasing cardiovascular death in patients with type 2 diabetes and CKD/heart failure down to an eGFR of 20 to 25 mL/min/1.73 m².
5A 58-year-old woman returns to the primary care clinic for management of resistant hypertension. Her seated blood pressure remains elevated at 152/96 mmHg despite verified adherence to maximally tolerated doses of amlodipine 10 mg daily, valsartan 160 mg daily, and indapamide 2.5 mg daily. Laboratory investigation shows serum sodium 140 mmol/L, potassium 4.2 mmol/L, and eGFR 68 mL/min/1.73 m². What is the recommended next step in pharmacological management?
A.Add atenolol 50 mg once daily
B.Add spironolactone 25 mg once daily
C.Add hydralazine 25 mg three times daily
D.Switch indapamide to furosemide 40 mg daily
Explanation: Resistant hypertension is defined as blood pressure that remains above goal despite concurrent use of three antihypertensive classes of different mechanisms (including a renin-angiotensin system blocker, a calcium channel blocker, and a thiazide/thiazide-like diuretic). The PATHWAY-2 trial and clinical guidelines establish low-dose spironolactone (25 to 50 mg daily) as the most effective fourth-line agent, provided serum potassium is < 4.5 mmol/L and eGFR is > 45 mL/min/1.73 m².
6A 60-year-old man who was started on atorvastatin 40 mg daily 6 weeks ago after an acute coronary event presents with generalized bilateral aching and heaviness in his thighs and upper arms. He has no dark urine, weakness, or fever. Serum creatine kinase (CK) is measured at 480 U/L (upper limit of normal 200 U/L), and serum creatinine is normal. What is the most appropriate initial management of this patient's statin-associated muscle symptoms?
A.Temporarily discontinue atorvastatin, allow muscle symptoms and CK to normalize, then rechallenge with a lower dose or an alternate statin
B.Immediately switch him permanently to gemfibrozil monotherapy
C.Continue atorvastatin 40 mg at the same dose and reassure him that tolerance will develop
D.Admit the patient to the inpatient medical ward for emergency intravenous hydration and urinary alkalinization
Explanation: Mild-to-moderate statin-associated muscle symptoms with mild CK elevation (< 4-5 times the upper limit of normal) without functional weakness or dark urine should be managed by temporarily withholding the statin for 2 to 4 weeks until symptoms resolve and CK normalizes. Once asymptomatic, rechallenge with a lower dose of the same statin or an alternate statin (such as rosuvastatin or pravastatin) or alternate-day dosing is recommended to re-establish cardioprotective lipid lowering.
7A 52-year-old male with long-standing hypertension and chronic kidney disease stage 3b (eGFR 38 mL/min/1.73 m², uACR 45 mg/mmol) attends his routine primary care review. His current clinic blood pressure is 138/86 mmHg. According to KDIGO guidelines, what is the recommended target blood pressure for this patient with chronic kidney disease and significant albuminuria?
A.< 150/90 mmHg
B.< 140/90 mmHg
C.< 130/80 mmHg (or standardized systolic blood pressure < 120 mmHg if tolerated)
D.< 110/70 mmHg
Explanation: International kidney guidelines (KDIGO) recommend that adults with chronic kidney disease and persistent significant albuminuria (uACR >= 3 mg/mmol) achieve a target blood pressure of < 130/80 mmHg, or a standardized office systolic blood pressure target of < 120 mmHg when well tolerated, to reduce cardiovascular events and slow nephropathy progression.
8An 76-year-old woman with a 20-year history of type 2 diabetes mellitus, mild cognitive impairment, and a history of recurrent falls lives alone. Her current regimen is glibenclamide 5 mg twice daily and metformin 850 mg twice daily. Her HbA1c is 6.6% (49 mmol/mol), and her home glucose logs frequently show readings between 3.2 and 4.0 mmol/L before meals. What is the most appropriate modification of her diabetes regimen?
A.Increase glibenclamide to 10 mg twice daily to achieve an HbA1c below 6.0%
B.Add sitagliptin 100 mg daily to smooth out preprandial fluctuations
C.Continue current therapy unchanged because her HbA1c indicates optimal glycemic control
D.Discontinue glibenclamide, replace it if needed with an agent that has minimal hypoglycemia risk, and relax the target HbA1c to 7.5% to 8.0%
Explanation: In older adults with frailty, cognitive impairment, or fall risk, hypoglycemia can cause catastrophic falls, fractures, and acute cardiovascular events. Long-acting sulfonylureas like glibenclamide are strongly discouraged due to high hypoglycemia risk. An individualized, relaxed HbA1c target of 7.5% to 8.0% (58-64 mmol/mol) prioritizes safety and quality of life over tight glycemic control.
9A 34-year-old man presents with persistent stage 2 hypertension (blood pressure 168/104 mmHg) diagnosed during a workplace screening. He has no significant past medical history and takes no medications. Routine laboratory tests reveal serum sodium 143 mmol/L, potassium 3.1 mmol/L (confirmed on repeat without hemolysis), bicarbonate 29 mmol/L, and creatinine 76 μmol/L. What is the most appropriate initial diagnostic screening test for his suspected secondary hypertension?
A.24-hour urinary free cortisol excretion
B.Plasma aldosterone-to-renin ratio (ARR)
C.Renal artery magnetic resonance angiography
D.Plasma free metanephrines
Explanation: Spontaneous hypokalemia combined with metabolic alkalosis in a young hypertensive patient strongly points toward primary aldosteronism (Conn syndrome). The recommended initial screening test is the morning plasma aldosterone-to-renin ratio (ARR) measured under standardized conditions, after correcting hypokalemia and addressing interfering medications.
10A 29-year-old man attends for health checkup. Physical examination reveals bilateral tendon xanthomas on his Achilles tendons and prominent corneal arcus. Fasting lipid testing demonstrates total cholesterol 9.8 mmol/L, LDL-C 7.6 mmol/L, HDL-C 1.1 mmol/L, and triglycerides 1.8 mmol/L. His father suffered a fatal myocardial infarction at age 42. Which genetic dyslipidemia is most likely, and what is the primary therapeutic target?
A.Heterozygous familial hypercholesterolemia; treat with high-intensity statin plus ezetimibe aiming for an LDL-C reduction of >= 50% (target < 1.4 to 1.8 mmol/L)
B.Familial hypertriglyceridemia; treat primarily with gemfibrozil aiming for triglycerides < 1.7 mmol/L
C.Familial dysbetalipoproteinemia (type III); treat with high-dose niacin
D.Polygenic hypercholesterolemia; treat with dietary sterols alone
Explanation: Tendon xanthomas, early corneal arcus, severe LDL-C elevation (> 4.9 mmol/L in adults), and premature coronary disease in a first-degree relative are classic phenotypic hallmarks of familial hypercholesterolemia (FH). Initial therapy requires immediate high-intensity statin therapy combined with ezetimibe, with PCSK9 inhibitors added if targets are not achieved.

About the Kuwait Board Family Medicine Exam

Summative examinations of the five-year Kuwait Family Medicine Residency Program (KFMRP), conducted under the governance of the Kuwait Institute for Medical Specialization (KIMS). The training program has maintained international affiliation and MRCGP(INT) accreditation since its founding, delivering structured postgraduate training across Kuwait's primary healthcare centers and hospital rotations. This OpenExamPrep bank is independent English-language MCQ practice mapped across the core KFMRP curriculum domains; it is not an official KIMS or RCGP paper and does not simulate the OSCE or Structured Skills Assessment (SSA) clinical components.

Exam sponsor: Kuwait Institute for Medical Specialization (KIMS) Examinations Office. The requirements and fees below concern the certification or admission exam, separate from our free practice resources.

Assessment

The five-year KFMRP curriculum uses continuous workplace-based assessment together with two exit examinations. The Part 1 examination after the second year consists of an MCQ part and an OSCE, both of which must be passed for promotion to registrar. The final exit examination for promotion to senior registrar comprises three parts: an Applied Knowledge Test (AKT), a written examination, and a Structured Skills (SS) clinical examination. KFMRP examination notices show the Structured Skills Assessment sat in separate English and Arabic sittings.

Time Limit

Not published

Passing Score

Not published by KIMS. Under the KIMS Examinations Policies and Procedures (s15.3-15.4), each residency program sets its own marking system and standard setting from its own psychometric approach, and all results are approved by the KIMS Secretary General. Under s15.1, candidates must sit and pass all examination components together.

Exam / Certification Fees

Not published

Exam sponsor website

Our practice resources: topics covered

We aim to reflect publicly available exam outlines and topic information in our study resources. Coverage, format, and difficulty may differ from the actual exam, and we cannot guarantee that every detail is accurate or current. Confirm exam requirements, fees, and policies with the official exam sponsor.

20%

Chronic Disease Management

Evidence-based ambulatory management of type 2 diabetes mellitus, hypertension, dyslipidemia, asthma, COPD, chronic kidney disease, and cardiovascular risk reduction in primary care.

15%

Maternal & Women's Health

Antenatal and postpartum care, routine screening in pregnancy, contraceptive counseling, abnormal uterine bleeding, cervical cancer screening, menopause, and common gynecological conditions.

15%

Child & Adolescent Health

Well-child surveillance, developmental milestones, national immunization schedules, pediatric acute respiratory illnesses, gastrointestinal disorders, pediatric dermatology, and adolescent health.

12%

Adult & Elderly Care / Geriatrics

Comprehensive geriatric assessment, frailty syndromes, polypharmacy and deprescribing, falls evaluation, osteoporosis management, and cognitive impairment and dementia.

10%

Mental Health in Primary Care

Primary care assessment and stepped care for major depressive disorder, generalized anxiety, panic disorder, somatoform disorders, insomnia, and substance misuse.

10%

Acute Primary Care & Urgent Presentations

Triage and initial stabilization of undifferentiated chest pain, acute dyspnea, red eye, acute abdominal pain, minor trauma, wound management, and urgent referrals.

10%

Dermatology, ENT & Ophthalmology

Common dermatological eruptions and benign lesions, acute and chronic otitis media, otitis externa, rhinosinusitis, epistaxis, acute pharyngotonsillitis, and ambulatory ophthalmologic complaints.

8%

Preventive Medicine, Screening & Consultation Skills

Adult immunizations, cancer screening guidelines, lifestyle interventions, evidence-based medicine principles, medical ethics, patient-centered consultation models, and primary health care organization.

Preparing for the Kuwait Board Family Medicine Exam

What You Need to Know

  • Passing score: Not published by KIMS. Under the KIMS Examinations Policies and Procedures (s15.3-15.4), each residency program sets its own marking system and standard setting from its own psychometric approach, and all results are approved by the KIMS Secretary General. Under s15.1, candidates must sit and pass all examination components together.
  • Assessment: The five-year KFMRP curriculum uses continuous workplace-based assessment together with two exit examinations. The Part 1 examination after the second year consists of an MCQ part and an OSCE, both of which must be passed for promotion to registrar. The final exit examination for promotion to senior registrar comprises three parts: an Applied Knowledge Test (AKT), a written examination, and a Structured Skills (SS) clinical examination. KFMRP examination notices show the Structured Skills Assessment sat in separate English and Arabic sittings.
  • Time limit: Not published
  • Exam / certification fees: Not published Official sources

Using Our Practice Resources

  • Work through all 100 available questions
  • Review every answer and explanation
  • Track weak areas and revisit them
  • Use our AI tutor for tough concepts

Frequently Asked Questions

What is the examination structure for the Kuwait Board in Family Medicine?

Assessment consists of continuous workplace-based evaluations across the five residency years, a Part 1 examination after R2 (combining written MCQs and an OSCE, both of which must be passed), and a Part 2 final exit exam comprising an Applied Knowledge Test (AKT) written component and a Structured Skills Assessment (SSA) clinical exam.

What languages are used in the Kuwait Board Family Medicine examinations?

Under KIMS Examinations Policies and Procedures (s14.1-14.2), examinations are offered primarily in English, and candidates must possess adequate written and oral English fluency. In addition, the Program Examinations Committee offers clinical skills assessments in both English and Arabic streams—specifically the Structured Skills Assessment (SSA-EN and SSA-AR)—to reflect clinical communication in Kuwait's primary healthcare centers.

What is the passing score and format for the written AKT exam?

KIMS does not publish an Angoff threshold, percentage pass mark, question count, or sitting duration. Under KIMS policy (s15.3-15.4), standard setting and psychometric calibration are determined by the Program Examinations Committee and approved by the KIMS Secretary General. Candidates must sit all components together and achieve passing marks in each section.

What is the relationship between the Kuwait Family Medicine Residency Program and the MRCGP(INT)?

The Kuwait Family Medicine Residency Program (KFMRP) has maintained international academic affiliation with the UK Royal College of General Practitioners (RCGP) since 1983 and holds MRCGP(INT) accreditation. Kuwait Board graduates are eligible to apply for MRCGP(INT) recognition under the terms established between KIMS and the RCGP.

Is this OpenExamPrep practice question bank affiliated with KIMS or the RCGP?

No. This question bank is an independent educational resource created by OpenExamPrep for self-study and revision. It is not endorsed by, affiliated with, or provided by KIMS or the Royal College of General Practitioners, and it does not simulate the OSCE or SSA clinical examination stations.